Research Topics
| Janet A EnglundSummaryAffiliation: University of Washington Country: USA Publications
| Collaborators
|
Detail Information
Publications
Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipientsJanet A Englund
Children s Hospital and Regional Medical Center, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98105, USA
Ann Intern Med 144:344-9. 2006..Human metapneumovirus (hMPV), a recently discovered respiratory virus, is associated with clinical disease in young and elderly persons...
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlersJanet A Englund
Pediatric ID, Children s Hospital and Regional Medical Center, 4800 Sand Point Way, NE W8851, Seattle, Washington 98105, USA
Pediatrics 118:e579-85. 2006....
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled studyJanet A Englund
Department of Pediatrics, Division of Infectious Diseases, Children s Hospital Research Institute, University of Washington, Seattle, WA, USA
Pediatr Infect Dis J 29:105-10. 2010..Infants less than 6 months of age are at high risk for influenza disease and influenza-related complications, but no vaccine is licensed for this population...
Maternal immunization with Haemophilus influenzae type b vaccines in different populationsJanet A Englund
Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way NE 8G, Seattle, WA 98105, USA
Vaccine 21:3455-9. 2003..Principles observed in these studies have potential application against other important neonatal pathogens...
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCTAngela P Campbell
Department of Pediatrics, University of Washington, Seattle, Washington, USA
J Infect Dis 201:1404-13. 2010..Few data exist on respiratory virus quantitation in lower respiratory samples and detection in serum from hematopoietic cell transplant (HCT) recipients with respiratory virus-associated pneumonia...
WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipientsJane Kuypers
University of Washington, Seattle, Washington 98102, USA
Emerg Infect Dis 18:1580-8. 2012..There were no associations with polyomavirus detection and acute graft versus host disease, cytomegalovirus reactivation, neutropenia, lymphopenia, hospitalization, or death...
Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipientsSu Mi Choi
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
J Infect Dis 206:1872-7. 2012..Among patients with LRD, viremia was associated with increased hazards of overall and influenza-associated death (hazard ratio 3.5, 1.1-12). Thus, influenza viremia may serve as marker for overall poor outcome...
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionAngela J Peck
Department of Pediatrics, Children s Hospital and Regional Medical Center and University of Washington, Seattle, WA, USA
Blood 110:1681-8. 2007..004). Subclinical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV...
Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot studyEmmanuel B Walter
Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
Pediatr Infect Dis J 28:1099-104. 2009..Although children less than 6 months of age have the highest risk for hospitalization related to influenza infection, influenza vaccine is not approved for these children...
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?Emmanuel B Walter
Duke Clinical Research Institute, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
Pediatrics 118:e570-8. 2006....
Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient careMin Xu
Dept of Laboratories, Seattle Children s Hospital, Seattle, WA 98105, USA
Am J Clin Pathol 139:118-23. 2013..Our results demonstrate that molecular technology can be successfully deployed in a nonspecialty, high-volume, multidisciplinary core laboratory...
Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipientsFilippo Milano
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Blood 115:2088-94. 2010..HRV and HCoV infections are common in the first 100 days after HCT, viral shedding lasts more than 3 weeks in half, and lower respiratory infection is rare...
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control studyDebie Vu
Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 1024, USA
Clin Infect Dis 45:187-93. 2007..However, no data exist regarding the use of oseltamivir as prophylaxis among patients undergoing hematopoietic stem cell transplantation (HSCT)...
Influenza-associated morbidity in children with cancerSarah K Tasian
Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Pediatr Blood Cancer 50:983-7. 2008..The clinical impact of influenza in children undergoing therapy for cancer is not well-described in the literature...
Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirusEmily T Martin
Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
Diagn Microbiol Infect Dis 62:382-8. 2008..Our study has described a significant relationship between viral load and markers of disease severity for both RSV and hMPV in a large population of children evaluated for respiratory disease...
Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipientsChristian Renaud
Seattle Children s Hospital, Seattle, WA, USA
Antivir Ther 17:175-91. 2012..Finally, new drugs have been developed to treat influenza virus, respiratory syncytial virus, parainfluenza virus and adenovirus with some promising results...
A comparison of 2 influenza vaccine schedules in 6- to 23-month-old childrenJanet A Englund
Division of Pediatric Infectious Diseases, Allergy, and Rheumatology, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Pediatrics 115:1039-47. 2005..Trivalent inactivated influenza vaccine (TIV) is recommended for all children ages 6 to 23 months. Delivering 2 doses of TIV at least 4 weeks apart to young children receiving this vaccine for the first time is challenging...
A prospective study of parainfluenza virus type 4 infections in children attending daycareMary P Fairchok
Department of Pediatrics, Madigan Army Medical Center, Tacoma, WA 98431, USA
Pediatr Infect Dis J 30:714-6. 2011..PIV-4 was second only to PIV-3, occurring in 9 of 87 (10%) PIV+ illnesses. PIV-4 illnesses were not more severe and not associated with a specific clinical syndrome...
Self-collection of foam nasal swabs for respiratory virus detection by PCR among immunocompetent subjects and hematopoietic cell transplant recipientsAngela P Campbell
University of Washington, Seattle, Washington, USA
J Clin Microbiol 51:324-7. 2013..004), respectively, and those from 140 URI samples from hematopoietic cell transplantation recipients were 88% and 85% (P = 0.56), respectively...
Respiratory viruses in children with cystic fibrosis: viral detection and clinical findingsJane L Burns
Department of Pediatrics, Division of Infectious Diseases, University of Washington and Seattle Children s Hospital, USA
Influenza Other Respi Viruses 6:218-23. 2012..In addition, associations between viral detection and respiratory symptoms are not well described...
Frequent and prolonged shedding of bocavirus in young children attending daycareEmily T Martin
Center for Clinical and Translational Research, Seattle Children s Research Institute, 1900 Ninth Avenue, Seattle, WA 98101, USA
J Infect Dis 201:1625-32. 2010..Little is known about human bocavirus (HBoV) persistence and shedding and the association between HBoV detection and the onset and resolution of respiratory symptoms...
Coronavirus-associated pneumonia in previously healthy childrenJudson Heugel
Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, WA, USA
Pediatr Infect Dis J 26:753-5. 2007..Here, we document the clinical courses of 2 previously healthy children with coronavirus-associated pneumonia...
H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patientsChristian Renaud
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Emerg Infect Dis 17:653-60; quiz 765. 2011..Emergence of oseltamivir resistance is frequent in immunocompromised patients infected with pandemic (H1N1) 2009 virus and can be associated with a wide range of clinical disease and viral kinetics...
Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infectionYae Jean Kim
Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Semin Respir Crit Care Med 28:222-42. 2007..Clinicians should appreciate the potential for the development of antiviral resistance to influenza antivirals in immunocompromised patients...
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsSu Mi Choi
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Blood 117:5050-6. 2011..Thus, our data suggest that infection with 2009 influenza A/H1N1 resulted in more severe respiratory disease in HCT recipients compared with seasonal influenza...
Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?Emmanuel B Walter
Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
Vaccine 28:4376-83. 2010..The role of age should be considered when assessing improved vaccines to enhance TIV immunogenicity and effectiveness in younger children...
Multiple viral respiratory pathogens in children with bronchiolitisHilary E Stempel
Seattle Children s Hospital Research Institute, University of Washington, Seattle, WA, USA
Acta Paediatr 98:123-6. 2009..The aim of the study was to describe the frequency of viral pathogens and relative frequency of co-infections in nasal specimens obtained from young children with bronchiolitis receiving care at a children's hospital...
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1Christian Renaud
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Clin Virol 52:70-8. 2011..However, immunocompromised patients infected with oseltamivir-resistant H1N1 experience potentially more risks of complication and transmissibility with few therapeutic options...
Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisionsJustin R Ortiz
Vaccine Development Global Program, PATH, Seattle, WA, United States
Vaccine 29:4439-52. 2011..Nonetheless, maternal influenza vaccination remains an important and potentially cost-effective approach to decrease influenza morbidity in two high-risk groups - pregnant women and young infants...
Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerationsTina Tan
Division of Infectious Diseases, Northwestern University s Feinberg School of Medicine, The Children s Memorial Hospital, Chicago, IL 60614, USA
Pediatr Infect Dis J 24:S83-6. 2005....
Detection of bocavirus in saliva of children with and without respiratory illnessEmily T Martin
Center for Clinical and Translational Research, Seattle Children s Research Institute, Washington 98101, USA
J Clin Microbiol 47:4131-2. 2009..hBoV was detected in saliva samples at asymptomatic enrollment in 3% (5/149) and during respiratory illness in 2% (2/106) of the cases. hBoV was detected in only 1/149 asymptomatic and 0/106 illness nasal samples...
Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experienceXuan Qin
Department of Laboratory Medicine, Microbiology Laboratory, Children s Hospital and Regional Medical Center, NE, Seattle, WA 98105 0371, USA
Antimicrob Agents Chemother 52:3909-14. 2008..These data have important implications for empirical antimicrobial strategies targeting serious pediatric infections. Further study of this problem is warranted...
Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infectionJames A Taylor
Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
Pediatr Res 68:252-7. 2010..9%, and accuracy of 73.3%. Parental impression is only a moderately accurate predictor of viral URI in children. Our URI symptom score provided a more accurate method for identifying children with viral URIs for clinical studies...
Emergence of oseltamivir-resistant pandemic H1N1 in an immunocompetent child with severe status asthmaticusChristian Renaud
Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
J Asthma 48:572-5. 2011..Pandemic influenza A (H1N1) may cause severe illness in pediatric patient with chronic lung disease...
Clinical disease in children associated with newly described coronavirus subtypesJane Kuypers
Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
Pediatrics 119:e70-6. 2007..In this study we examined the prevalence of 4 human coronaviruses, including subtypes OC43, 229E, and the recently described NL63 and HKU1 in a pediatric population presenting to a children's hospital...
Multitarget PCR for diagnosis of pertussis and its clinical implicationsXuan Qin
Microbiology Laboratory, Department of Laboratories and Pathology, A9601, Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
J Clin Microbiol 45:506-11. 2007..This consensus generating real-time PCR approach permits a sensitive detection, as well as an accurate species identification of the causative Bordetella pathogens for the timely management of patients...
Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalizationDanielle M Zerr
Children s Research Institute, and Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
Pediatrics 121:345-8. 2008..We performed this study to determine the frequency of previous hospitalization among children hospitalized with influenza...
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazoleAlexander Imhof
Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Clin Infect Dis 39:743-6. 2004..Minimal inhibitory concentrations were > or =1 microg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis...
Maternal immunization with inactivated influenza vaccine: rationale and experienceJanet A Englund
Department of Pediatrics, Children's Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way NE # 8G, Seattle, WA 98105, USA
Vaccine 21:3460-4. 2003..Increased influenza vaccine use during pregnancy has the potential to benefit both the woman and her infant...
BK nephropathy in pediatric hematopoietic stem cell transplant recipientsPriya S Verghese
Department of Pediatrics, University of Washington and Seattle Children s Hospital, Seattle, WA 98105, USA
Pediatr Transplant 13:913-8. 2009....
Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infectionCaroline J Chantry
Department of Pediatrics, University of California Davis Medical Center, Sacramento 95817, USA
Pediatr Infect Dis J 22:1033-9. 2003..The relationships among weight and height growth, viral load and survival in HIV-infected children remain unclear...
Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiencyIngrid S Lundgren
Division of Infectious Diseases, Seattle Children s Hospital, Seattle, WA 98105, USA
Pediatr Infect Dis J 31:95-7. 2012..We found that 80% of patients receiving only 21 days of antibiotics survived to 12 months beyond hematopoietic cell transplant, whereas only 25% of patients who required longer treatment for PCP survived to stem cell engraftment...
Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipientJohn D Scott
Department of Medicine, University of Washington, Harborview Medical Center, 325 Ninth Avenue, Box 359938, Seattle, WA 98104 2499, USA
J Clin Virol 31:96-9. 2004..Stem cell transplant recipients are susceptible to pulmonary infections, including influenza A. Typically, isolated influenza pneumonia has a diffuse, interstitial infiltrate pattern...
Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illnessLindsey N Johnson
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA
Pediatr Infect Dis J 23:881-2. 2004..We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients...
Effectiveness of school-based influenza vaccinationJames C King
Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
N Engl J Med 355:2523-32. 2006..Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities...
Antiviral therapy of influenzaJanet A Englund
Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA
Semin Pediatr Infect Dis 13:120-8. 2002..No direct comparisons of any of these antiviral agents has been performed; all result in clinical improvement approximately 1 to 2 days earlier in otherwise healthy children when therapy is initiated within 48 hours of onset of symptoms...
Response to changes in antiretroviral therapy after genotyping in human immunodeficiency virus-infected childrenNicole J Cohen
Department of Pediatrics, University of Chicago Hospitals, IL, USA
Pediatr Infect Dis J 21:647-53. 2002..However, medication history alone does not appear to be an adequate alternative to genotyping in choosing salvage regimens in antiretroviral agent-experienced children...
Duration of immunity against pertussis after natural infection or vaccinationAaron M Wendelboe
Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
Pediatr Infect Dis J 24:S58-61. 2005..Further research into the rate of waning of vaccine-acquired immunity will help determine the optimal timing and frequency of booster immunizations and their role in pertussis control...
Antimicrobial susceptibility of Bordetella pertussis isolates in the state of WashingtonEmmanouil Galanakis
Int J Antimicrob Agents 29:609-11. 2007
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitorsJanet A Englund
University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
Pediatr Infect Dis J 23:15-22. 2004....
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutantsJohn P DeVincenzo
University of Tennessee, LeBonheur Children s Medical Center, Memphis 38103, USA
J Infect Dis 190:975-8. 2004..Palivizumab bound to all 371 RSV isolates able to be evaluated, including 25 from active-palivizumab recipients. The palivizumab epitope appears to be highly conserved, even in infants receiving prophylaxis with palivizumab...
Influenza vaccine for young children: two doses are better than oneKathleen Maletic Neuzil
J Pediatr 149:737-8. 2006
Role of maternal pertussis antibodies in infantsAnnelies Van Rie
Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
Pediatr Infect Dis J 24:S62-5. 2005..The limited data on neonatal and maternal pertussis immunization are promising and call for further research to reduce the vulnerability of young infants to pertussis disease...
Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unitAdrienne G Randolph
Department of Anesthesia, Harvard Medical School, Boston, MA, USA
Pediatr Infect Dis J 23:990-4. 2004..Although bacterial pneumonia in this cohort may be more prevalent, overdiagnosis is common...
